Stocksigma LogoStocksigma Logo

Medicamen Biotech Board to Consider Q2 FY27 Results on 13th Nov'26

Medicamen Biotech Limited announced that its Board of Directors will meet on 13th Nov'26 to consider and approve standalone and consolidated unaudited

Medicamen Biotech Board to Consider Q2 FY27 Results on 13th Nov'26

Medicamen Biotech Ltd 路 Intimation 路 13 Nov 2026, 5:30 am

Medicamen Biotech Board to Consider Q2 FY27 Results on 13th Nov'26 Medicamen Biotech Limited announced that its Board of Directors will meet on 13th Nov'26 to consider and approve standalone and consolidated unaudited financial results for the quarter and half year ended 30th Sep'26. Per insider trading regulations, the trading window for dealing in company securities has been closed for designated persons since 1st Oct'26 and will reopen 48 hours after the declaration of the financial results to stock exchanges.

Original exchange filing (PDF)

More announcements from Medicamen Biotech Ltd

All Medicamen Biotech Ltd announcements